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There is considerable evidence that thymus-derived (T) and bone marrow-derived 
(B) lymphocytes share similar VH-region products on the cell surface (1, 2). Neverthe- 
less,  the molecular nature of the T-cell receptor still remains essentially unresolved. 
Studies  by  Binz  and  Wigzell  (3,  4)  in  the  rat  demonstrated  that  anti-idiotypic 
antiserum raised against T-lymphocyte receptors or against alloantibodies which were 
specific for the same alloantigens can inhibit a variety of T-cell functions. It has also 
been  reported  by  Eichmann  and  his  colleagues,  who  investigated  the  A5A  (anti- 
streptococcal) immune response in the mouse, that anti-idiotype antibodies raised in 
guinea pig, when passively administered  to A/J  mice, could  preferentially activate 
suppressor T  cells or helper T  cells, depending on the isotype of the antibodies used 
(5, 6). Another series of experiments exploring the similarity of receptors on T  and B 
lymphocytes dealt with  the response to the  hapten,  4-hydroxy-3-nitrophenyl acetyl 
(NP).I It was found that the primary anti-hapten antibody response to hapten protein 
conjugate  (NP-chicken  globulin),  is  heteroclitic  in  mice of the Igh-1 b allotype;  i.e., 
these  antibodies  bind  an  analogue  of the  hapten,  4-hydroxy-5-iodo-3-nitrophenyl 
acetyl  with  greater  affinity  than  the  immunizing  hapten  itself  (7).  In  addition, 
antigen-binding  material isolated from T  cells also exhibited similar fine specificity 
(8).  More  germane  to  the  studies  reported  here  are  the  recent  findings  (9)  that 
delayed-type hypersensitivity to the  same hapten  also  demonstrates  heterocliticity. 
Furthermore, this T-cell-mediated specificity is also genetically linked  to the heavy- 
chain Igh-1 b allotype, as in the antibody response. 
In an attempt to gain more insight into the cellular regulation of T-cell-mediated 
immune response and  the  nature  of the cell receptor, we have initiated  a  series of 
studies on delayed-type hypersensitivity to azobenzene-arsonate (ABA)  (10-12). This 
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is  a  system where  extensive  information  on the  humoral  aspect  of the  immunity is 
available  (13,  14).  The antibody response of A/J mice to ABA conjugates is charac- 
terized by the presence of cross-reactive idiotypic  (CRI) determinants  on 20-70% of 
anti-ABA antibodies as demonstrated with anti-idiotypic antibodies raised in rabbits. 
In this paper, we will present  evidence that rabbit  antibodies  raised  against  anti- 
ABA CRI  determinants,  when  passively  administered  to A/J  mice at  the  time  of 
immunization, suppress the development of DTH to ABA-coupled cells. Furthermore, 
we have performed adoptive transfer experiments which provide direct evidence that 
the suppression  is a  consequence of the activation of suppressor T  cells by anti-CRI 
antibodies.  The  significance  of these  findings  will  be  discussed  in  terms  of genetic 
restrictions of suppressor cells operating in the immune network. 
Materials and Methods 
Mice.  A/J (H-2  a, Igh-1  e) and BALB/c (H-2  a, Igh-l') female mice were obtained from The 
Jackson Laboratory, Bar Harbor, Maine. All C.AL-20 (H-2  d, Igh-1  d) female mice were obtained 
from breeding colonies established at Brandeis University. The C.AL-20 strain was originally 
produced  by  Michael  Potter  at  the  National  Institutes  of Health.  All  animals  in  these 
experiments were 8-10 wk of age at the time of the experiment and each experimental group 
consisted of at least four animals. 
Preparation of  Antigen and Antigen-coupled CeUs.  The diazonium salt ofp-arsanilic acid (Eastman 
Kodak Co., Rochester, N.Y.) was prepared as described earlier  (10). A  40-mM solution was 
activated as previously described and conjugated to single cell suspensions of erythrocyte-frce 
splenocytes at a final concentration of 10 mM. After washing in Hanks' balanced salt solution, 
the ABA-coupled cells were used to induce delayed-type hypersensitivity (DTH) as previously 
described (10). 
Induction and Elicitation of DTH to ABA-coupled Cells.  To induce DTH to ABA, a total of 3 
x  10  7 ABA-coupled syngeneic cells  were injected subcutaneously into separate sites  on the 
dorsal flanks of mice. Challenge was performed 5 d later by injecting 25 #1 of 10 mM diazonium 
salt ofp-arsanilic acid into the left footpad. 
Measurement of Footpad Swelling.  24  h  after  the  footpad  challenge,  DTH  reactivity  was 
assessed by measuring the swelling of the footpad using a Fowler micrometer (Schlesingers  For 
Tools  Ltd.,  Brooklyn,  N.  Y.).  The  magnitude  of the  DTH  reaction  was  expressed  as  the 
increment  of thickness of the challenged left  footpad as compared with the untreated  right 
footpad. Responses are given in units of 10  -s in  :t: SEM. Statistical analysis of the difference 
of data obtained utilized the two-tailed Student's t test. 
Sensitization and Elicitation of Contact Sensitivity.  Mice were sensitized with 7% TNCB (2,4,6- 
trinitrochlorobenzene,  Matheson  Scientific,  Cincinnati,  Ohio)  in  4:1  acetone:olive  oil  by 
application of 100 #1 of this solution on the shaved abdominal skin.  Elicitation was done 5 d 
after sensitization by applying 20 #1 of 1% TNCB in olive oil to the dorsal surface of the ears. 
Ear swelling was measured 24 h later with a Mitutoya engineer's micrometer (Mitutoya/MTI 
Corp., New York) and is expressed in units of 10  -4 in. 
Cydophosphamide Treatment.  Mice were injected  i.p.  with  50 mg/kg of cyclophosphamide 
(Mead Johnson and Co., Evansville, Ind.) diluted in distilled water. 
Preparation of Anti-idiotypic Antibodies.  Anti-idiotypic  antibodies  against  the  cross-reactive 
idiotype  (CRI)  characteristic  of the  anti-ABA  antibodies  of A/J  mice were  prepared  and 
quantitated  as  described earlier  (15).  Preparation  of the F(ab')2 fragments of the anti-CRI 
antibodies has also been described elsewhere (12). 
Induction of Suppressor Cells with  Anti-idiotypic  Antibodies.  Anti-idiotypic  antibodies  (2  #g 
idiotype binding capacity (IBC))  were injected  intravenously into appropriate  animals  in a 
volume of 0,2 mt for 5 successive  ~lays. On day 6, the mice were sacrificed and used as donors 
of suppressor cells. 
Transfer of Suppressor Cells.  Animals  which  had  received  anti-idiotypic  antibodies  on  5 
successive  days were sacrificed.  Spleens  from such  animals  were removed and  a  single cell 
suspension was prepared. The ceils were washed twice in Hanks' balanced salt solution (HBSS) 1218  ANTIGEN- AND RECEPTOR-DRIVEN REGULATORY MECHANISMS 
and counted,  and  50  ×  10  ~ cells in 0.5  ml were injected i.v. into normal  recipients. Control 
mice received either no cells or cells from normal donors. The recipient and control mice were 
immunized with ABA-coupled cells 1-2 h  after transfer as described earlier. 
Affinity  Chromatography of Anti-CRl Antiserum.  Specifically purified A/J anti-ABA antibodies 
were  coupled  to  Sepharose  4B  beads  (Pharmacia  Fine  Chemicals,  Div.  of Pharmacia  Inc., 
Piscataway,  N. J.)  as  described  earlier  (12).  Anti-CRI antibodies  (10 ~g IBC  in  1 ml)  were 
passed through the column and antibodies that remained adsorbed to the column were rapidly 
eluted  with  a  glycine-HC1 buffer,  pH  2.8.  The  eluate  was  neutralized  to  pH  7.0  with  1 N 
NaOH.  Both the filtrate and the eluate were concentrated to the original volume by negative 
pressure dialysis and then assessed for their ability to suppress ABA-specific DTH. 
Anti-O and Anti-MIg Serum Treatment.  Anti-Thyl.2 hybridoma antiserum  donated by Dr. P. 
Lake,  University  College,  London,  and  polyvalent  anti-mouse  immunoglobulin  (anti-MIg) 
serum were used as described earlier (10).  Briefly, 1 ×  10  a cells were incubated with  1 ml of a 
1:25 dilution of anti-Thyl.2 hybridoma antiserum or a  1:20 dilution of anti-MIg serum for 45 
min at 0°C, washed once in HBSS and then incubated again with  1.0 ml of a  h 10 dilution of 
Low Tox rabbit complement (Cedarlane Laboratories, London, Ontario)  for 30 min. at 37°C, 
The cells were then washed twice in HBSS and resuspended  for cell transfer. 
Results 
Effect  of Anti-CRI Antibodies on  the  Induction of DTH  to  ABA.  Experiments  were 
initiated to examine the effect of passively administered anti-CR! antibodies on the 
induction of ABA-specific delayed-type hypersensitivity. A/J mice were immunized 
with ABA-coupled syngeneic spleen cells subcutaneously as  described in  Materials 
and Methods.  Some of these animals received normal rabbit serum  (NRS)  or anti- 
CRI antibodies (2 btg IBC per mouse for 5 successive days) in equivalent volumes. On 
day 5, they were challenged with 25 #1 of the diazonium salt ofp-arsonilic acid in the 
footpad, and the increase in footpad swelling was measured 24 h later. 
The results of such an experiment are shown in Table I. As can be seen, animals 
receiving normal rabbit serum were able to manifest significant levels of ABA-specific 
immunity as compared with untreated control animals. In contrast, A/J mice injected 
with anti-CRI antibodies previously absorbed with A/J splenocytes failed to develop 
significant immunity to ABA. 
Dose Response of Inhibition by Anti-CRI Antibodies.  The minimum  amount of anti- 
CRI antibodies necessary to inhibit DTH to ABA-coupled cells was next determined. 
The results are depicted in Fig.  1. Animals which received 0.1  #g IBC of anti-CRI 
antibodies still showed significant immunity, as compared to control animals. How- 
TABLE  I 
Passively Administered Anti-CRI Antibody Inhibits ABA-Spec~c DTH 
Units of footpad 
Group  Immunization  Treatment*  swelling:~ ×  10 -3  P value 
in  ±  SEM 
I  3 x  107 ABA-sc (s.c.)  12  ±  1.0  -- 
II  3 X  107 ABA-sc (s.c.)  4.5  ±  0.7  <0.001  Anti-CRI antibody 
(2 #g IBC/mouse 
day) 
NRS  III  3 X  107 ABA-sc (s.c.)  11  ±  1.2  NS 
IV  --  --  3 ±  0.6  <0.001 
* Anti-CRI antibodies were injected (immediately after immunization) i.v. at 2 #g IBC per day for five 
successive days  (10 #g IBC total). 
:1: Challenges were done 5 d after immunization by injecting 25 btl of diazonium salt ofp-arsanilic acid in 
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FIG.  1.  Dose  response of inhibition by anti-CRI antibodies. Normal A/J mice were immunized 
with 3 X l0  T  ABA-coupled  syngeneic  spleen eels (ABA-sc)  subcutaneously.  They were then injected 
with 2 #g IBC of anti-CRI antibodies in 0.2 ml (i.v.) for 5 successive days (10 #g IBC total). On day 
5, they were then challenged in the footpad with diazonium salt ofp-arsanilie acid and the increase 
in footpad swelling was measured 24 h later. 
ever, all the animals that received from 1 to 10 #g IBC ofanti-CRI showed significant 
reduction in ABA-specific DTH. This clearly demonstrated that the ability of anti- 
CRI antibodies to inhibit DTH is a dose-dependent phenomenon. 
Inhibition  of DTH  by Anti-CRl Antibodies  Requires  Whole  Intact  Molecules;  Suppressive 
Activities  Can  Be  Removed  by  Passage  through Idiotype-coupled  Sepharose Immunoad- 
sorbents.  We next investigated whether inhibition of DTH by passively administered 
rabbit anti-CRI antiserum requires intact antibody molecules, by examining whether 
the F(ab')2 fragments of the same antibodies also inhibit ABA-speeific DTH. F(ab')2 
fragments of the anti-CRI antibodies were therefore prepared precisely as described 
earlier  (12).  Animals were immunized with ABA-coupled cells  and were then given 
either anti-CRI antibodies or the F(ab')2 fragments of anti-CRI intravenously. The 
volumes were adjusted so that the IBC of each antiserum was the same. 
The results presented in Fig. 2 indicate that in mice given intact anti-CRI the DTH 
response  was  suppressed  almost  to  the  background level.  Inoculation of an  equal 
amount of F(ab')z fragments  (in  terms  of IBC)  had  no significant  effect  on DTH. 
Furthermore, anti-CRI antibodies, after passage through an immunoadsorbent pre- 
pared using antibodies possessing the CRI, were incapable of suppressing ABA DTH. 
Nevertheless, the suppressive capacity could be recovered from this immunoadsorbent 
by elution with acid.  From these studies we can conclude that suppression by anti- 
CRI requires  the  whole intact  molecule and  is  not  a  result  of contamination with 
nonspecific antibodies in the rabbit anti-CRI antiserum. 
Inhibition  of DTH by Anti-CRI Antibody is Antigen  Specific.  The antigen specificity of 
the inhibition of DTH by anti-CRI antibody was next examined. Experiments were 
done  to  investigate  whether  anti-CRI  will  inhibit  DTH  to  an  unrelated  hapten, 
TNCB, known to induce T-cell-dependent DTH responses. A/J mice were immunized 
with  ABA-coupled cells  subcutaneously on  the  dorsal  flanks,  whereas  TNCB  was 
applied on the shaved abdomen. Mice were treated either with anti-CRI or normal 1220  ANTIGEN- AND  RECEPTOR-DRIVEN  REGULATORY  MECHANISMS 
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FIO. 2.  Inhibition of DTH  by anti-CRI  antibodies  requires  the  whe[e  intact  molecules and 
suppressive activities can be removed by passage through  idiotype-coupled Sepharose immunoad- 
sorbent. Normal A/J  7  mice were immunized with 3 X  10  ABA-sc  subcutaneously. They were then 
injected with either intact anti-CRI antibodies or F(ab')2 of anti-CRI (2 #g/d for 5 d) or the filtrate 
of anti-CRI passed through a CRI Sepharose column, or eluate (low pH)  of anti-CRI bound to 
CRI-Sepharose  column.  On  day 5,  these animals,  with  the appropriate control  animals,  were 
challenged  with the diazonium  salt  of p-arsanilic  acid in  the footpad  and increases in  footpad 
swelling were measured 24 h later. 
rabbit serum  for 5  successive days. Challenges were performed by injecting 25 lal of 
ABA diazonium salt in the right footpad to measure for ABA specific immunity and, 
in addition, 20 lal of TNCB  was applied onto the dorsal side of the ear to assay for 
TNCB-specific immunity. The increases in footpad and ear swelling were measured 
24 h  after challenge as described in Materials and Methods. 
Fig. 3 presents the results of a representative experiment. Animals that are sensitized 
with ABA-coupled cells and TNCB developed significant immunity to both ABA and 
TNCB.  As predicted from our earlier results, animals which received anti-CRI failed 
to develop immunity to ABA. Nevertheless, they were still fully capable of responding 
to the unrelated  hapten, TNCB.  Normal  rabbit serum  had  no  discernible effect on 
ABA  DTH  or  on  the  T-cell-dependent  ear  swelling  in  response  to  TNCB.  Thus, 
suppression of ABA-DTH mediated by anti-CRI antibodies is hapten-specific. 
Activation  of  Suppressor  Cells  with  Passively Administered  aAnti-CRI  Antibodies. 
Experiments were undertaken to ascertain whether the inhibition induced with anti- 
CRI  antibodies is a  result of the activation of suppressor cells or simply a  result of 
direct blockade or elimination of immune T  cells that  are specific for ABA by anti- 
CRI antibodies. 
Animals were treated with either normal rabbit serum or anti-CRI antibodies for 
5 successive days. On day 6, these animals were sacrificed and used as the donors of 
suppressor cells.  Fig.  4  presents  the  results of a  typical experiment.  Spleen,  lymph 
node, or thymus cells obtained from anti-CRI-treated animals were able to adoptively 
transfer suppression to naive recipients. In contrast, the same number of spleen cells MAN-SUN SY  ET AL.  1221 
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Fro.  3.  Antigen specificity of suppression induced  with  anti-CRl  antibodies.  A/J  mice were 
immunized subcutaneously with  3  X  10  7 ABA-sc and/or contact  sensitized with  100 #1 of 7% 
TNCB. Immediately after immunization, groups of mice were injected (i.v.) with 2 btg IBC of anti- 
CRI antibodies or normal rabbit  serum (NRS) for 5 successive days. On day 5, the  mice were 
challenged with diazonium salt ofp-arsanilic acid in the footpad and/or with 20 #1 of 1% TNCB on 
the ear. The increase in footpad and ear swelling was measured 24 h after challenge. 
obtained  from NRS-treated  animals  were unable  to transfer any detectable level of 
suppression. 
From these studies we concluded that  anti-CRI antibodies  inhibit  ABA-DTH by 
activating suppressor cells. The spleen was found to be the best source of suppressor 
ceils whereas lymph node and thymus were also found to contain significant numbers 
of suppressor cells. 
Failure of anti-CRI Antibody to  Inhibit  ABA-Specific  DTH  in  Animals  Pretreated with 
Cyclophosphamide.  The ability of spleen cells from anti-CRI treated animals to transfer 
suppression suggested that suppressor cells were involved in this inhibition. Neverthe- 
less  this  did  not  rule  out  the  possibility  that  anti-CRI  antibody  might  also  work 
directly on immune T  cells. To address this question, we employed cyclophosphamide 
pretreatment, which has been shown to be able to selectively eliminate suppressor cell 
precursors  (16-19).  A/J mice were pretreated  with cyclophosphamide  (50 mg/kg)  2 
d  before  immunization  with  ABA-coupled cells.  They were  then  given  either  anti- 
CRI or normal rabbit serum. The results presented  in Fig. 5 showed that cyclophos- 
phamide  pretreatment  prevented  anti-CRI  antibodies  from inhibiting  ABA-specific 
DTH  reactivity as compared to animals which were not pretreated  with cyclophos- 
phamide.  These  findings  therefore  provide evidence that  the  inhibition  of DTH  by 
anti-CRI antibodies is mainly a result of the cyclophosphamide-sensitive induction of 
suppressor cells. 
Suppressor Cells Induced by Anti-CRI Antibodies Are  Sensitive to  Treatment with  Anti-O 
Antiserum  Plus  Complement.  The  demonstration  that  anti-CRI  treatment  induces 
suppressor cells, before antigen exposure, raised the issue of the phenotype of the cells 
responsible for the transfer of suppression.  To examine this question, suppressor cells 
were  generated  by  passively  administered  anti-CRI  antibodies,  before  transfer  to 
naive recipients.  They were subjected to negative selection with anti-Thy  1.2 antise- 
rum or anti-MIg serum and complement as described in Materials  and Methods. As 
shown  in  Fig.  6,  the  ability  of cells  to adoptively  transfer  suppression  to ABA was 1222  ANTIGEN-  AND  RECEPTOR-DRIVEN  REGULATORY  MECHANISMS 
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Fla.  4.  Induction of suppressor cells with anti-CRI  antibodies.  Normal  A/J  mice were  injected 
(i.v.)  with 2 #g of IBC of anti-CRI or NRS for 5 successive days. On day 6, they were sacrificed and 
single cell suspensions were prepared  from their draining lymph nodes, spleen, and thymus. Fifty 
million viable cells were then transferred to naive recipients. All recipients were then immunized 
with 3  ×  107 ABA-sc subcutaneously within 2 h after cell transfer. 5 d  later, they were challenged 
in  the footpad  with  diazonium salt  of p-arsanilic acid  and  the increase in  footpad  swelling was 
measured 24 h after challenge. 
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FIG.  5.  Failure  of anti-CRI  antibodies  to  inhibit  ABA-specific DTH  in cyclophosphamide pre- 
treated animals. Normal A/J mice were treated with cyclophosphamide (50 mg/kg) or HBSS 2 d 
before immunization with 3  ×  107 ABA-sc subcutaneously. Immediately after immunization, they 
were then injected with normal rabbit  serum (NRS)  or anti-CRI antibodies (2 ~g IBC/day)  for 5 
successive days. 5 d later, they were then challenged with diazonium salt ofp-arsanilic acid and the 
increase in footpad swelling was measured 24 h  later. MAN-SUN  SY  ET  AL. 
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FIG.  6.  Sensitivity  of suppressor cells  to  anti-Thy  1.2  anti-serum and  complement.  A/J  mice 
injected with 2 #g IBC/d of anti-CRI antibodies for 5 successive days were the donors of suppressor 
cells.  On  day 6,  single cell  suspensions were  prepared  from  the spleen.  Before  transfer to  naive 
recipients, the cells were  treated  in  vitro with  either normal mouse serum (NMS),  anti-Thy  1.2 
antiserum, or anti-MIg serum and complement. Recipients and appropriate controls were immu- 
nized with 3  ×  10  v ABA-SC subcutaneously within 2 h  after cell transfer. Challenges were done 5 
d later with diazonium salt ofp-arsanilic acid and the increase in footpad swelling was measured 24 
h later. 
sensitive to treatment with anti-Thy  1.2 plus complement. In contrast, spleen cells 
treated with normal mouse serum or anti-MIg serum plus complement still retained 
their ability to transfer suppression. These studies establish that anti-idiotype can be 
used to induce antigen-specific Thy 1.2-positive suppressor cells which are effective in 
suppressing DTH induced by ABA-coupled cells. 
Genes Controlling the Inhibition  of DTH by Anti-CRI Antibodies Are Linked to the Heavy- 
chain Igh-1 Allotype  Locus.  It is now well established that genes linked to the heavy- 
chain allotype locus are required for the expression of idiotypes both in T  and B cells 
(20-22).  Experiments were designed to examine whether anti-CRI antibodies raised 
against  A/J  (H-2  a,  Igh-1 e)  anti-ABA  antibodies  can  suppress  ABA  immunity in 
allotype-matched C.AL-20  mice  (H-2  d,  Igh-1 d)  and  allotype-mismatched BALB/c 
mice (H-2  d, Igh-la). It should be noted again that C.AL-20 and BALB/e mice are 
congenic, differing only at the Igh-1 locus. C.AL-20 mice, but not BALB/c, produce 
humoral anti-ABA antibodies with the CRI (20). 
The results are shown in Fig. 7. Anti-CRI antibodies significantly inhibited ABA 
DTH immunity in both A/J and C.AL-20 mice. However, the same amount of anti- 
CRI antibodies administered to BALB/e mice was unable to detectably inhibit ABA 
DTH. Thus, inheritance of the ability of anti-CRI antibodies to activate suppressor 
T  cells is also linked to the heavy-chain Igh-1 allotype locus. 
Discussion 
Delayed hypersensitivity (DTH)  to ABA in  mice is a  T-cell-dependent  antigen- 
specific phenomenon. Recently, we have found that although subcutaneous injection 
of ABA-coupled cells induces immunity, intravenous injection of the same preparation 
stimulates the development of antigen-specific suppressor T  cells.  Suppressor T  cells 1224  ANTIGEN- AND  RECEPTOR-DRIVEN  REGULATORY MECHANISMS 
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Fro.  7.  Inhibition  of ABA-specific DTH by anti-CRl antibodies  is linked to heavy-chain  Igh- 
allotype. Normal BALB/c  (H-2  a, Igh- la), A/J (H-2  a, Igh-1  ~) or C.AL-20 (H-2  a, Igh-1  d) mice were 
immunized  with 3  X  107 ABA-coupled syngeneic spleen cells subcutaneously.  Immediately after 
immunization, they were injected with NRS or anti-CRI antibodies (2 #g IBC/day) for 5 successive 
days. On day 5, they were challenged with diazonium salt ofp-arsanilic  acid in the footpad and the 
increase in footpad swelling was measured 24 h later. 
upon  adoptive  transfer  render  the  recipient  animals  unresponsive  to  subsequent 
subcutaneous  immunization  with ABA-coupled cells. 
In this paper we have shown that passively administered anti-CRI antibodies cause 
the stimulation  of ABA suppressor T  cells comparable to those induced  by antigen- 
coupled cells. Intravenous injection of minute amounts ofanti-CRI antibodies induces 
immune unresponsiveness,  apparently mediated by suppressor T  cells, whereas F(ab')~ 
preparations  of  the  same  anti-CRI  antibodies  were  unable  to  induce  discernible 
suppression.  It  was  therefore  concluded  that  the  induction  of antigen-specific  sup- 
pressor T  cells by this regimen requires  the intact  antibody.  The contribution  of the 
Fc  portion  of the  anti-idiotype  molecule  for the  activation  of regulatory  T  cell  has 
been previously observed by Hart and  his coworkers  (23).  At present  no satisfactory 
explanation  is readily available for this requirement  of the Fc piece and experiments 
to resolve this tissue are in progress. 
The  ability  of passively  administered  anti-idiotype  antibody  to  induce  a  state of 
idiotypic suppression has been reported in many different experimental systems. Such 
experiments  have been carried out  in viva (24)  and  in vitro  (25).  Eichmann  and  his 
co-workers (5, 6), studying the response of mice to group A  Streptococcal polysaccha- 
ride demonstrated that passively administered anti-idiotype (anti-A5A) also suppresses 
the  expression  of idiotype  on  anti-A5A  antibodies.  Further  studies  from  the  same 
group  have shown that although  the IgG1 fraction of anti-A5A  will  induce  helper T 
cells,  intravenous  injection  of the  IgG2 fraction  preferentially  induced  suppressor  T 
cells.  This  was  considered  at  the  time  to  reflect  different  complement  activation 
properties  of the  isotypes  used.  Owen  et  al.  found  that  large  numbers  of idiotype- 
specific suppressor  T  cells can  be generated  by hyperimmunizing  a  recipient  mouse 
after administration  of anti-idiotypic  antibodies  and  allowing  a  rest  period  of 8-12 MAN-SUN SY ET AL.  1225 
wk  after  immunization  (26).  With  this  regimen,  nearly  all  the  idiotype-specific 
suppressor  T  cells  that  are  active  in  the  humoral  response could  be  removed by 
binding to erythrocytes coated with Fab fragments of antibodies carrying the major 
idiotype. Thus the suppressor cells had anti-idiotypic receptors. Suppressor cells with 
idiotypic (27) and anti-idiotypic (28) receptors have been identified by other investi- 
gators. Eichmann states that his attempts to lyse suppressor T cells with anti-idiotypic 
antibodies plus complement have occasionally but inconsistently been successful (23), 
an observation consistent with the presence of more than one type of idiotype-specific 
suppressor T  cell. 
The present studies of the ability of anti-CRI antibodies to completely abrogate the 
development of ABA-specific DTH also revealed a  fundamental difference between 
the effect of anti-CRI on T-cell-mediated DTH and on antibody responses to ABA- 
protein conjugates.  In the antibody studies  it was  found that  injection of anti-CRI 
antibodies prevented the expression of idiotype; however there was no concomitant 
suppression of the formation of anti-ABA antibodies inasmuch as the total level of 
anti-ABA antibodies remained the same (29). The idiotypes on anti-ABA antibodies 
of such  mice  are  generally  absent  or  present  at  very low  concentration  in  other 
immunized mice, either suppressed or nonsuppressed (30). In contrast, DTH to ABA 
was  almost completely suppressed  by anti-CRI  antibody. One explanation for this 
discrepancy is that the T-cell repertoire may be somewhat more restricted than the B- 
cell counterpart and makes greater use of major cross-reactive idiotypes (8). Alterna- 
tively, the suppressor T  cells which suppress ABA-specific DTH represent a different 
regulatory subset than those responsible for the suppression of antibody formation. It 
is possible that one is antigen specific and hence, idiotypic whereas the other may be 
idiotype specific and therefore anti-idiotypic. It is also conceivable that the two cell 
types may be mutually stimulatory. Preliminary results indicate that Ts induced by 
anti-CRI antibody bear idiotypic determinants on their cell surface because they can 
be lysed by anti-CRI and complement. 
Because  anti-CRI  antibodies  failed  to  inhibit  DTH  in  animals  pretreated  with 
cyclophosphamide in doses known to eliminate suppressor T-cell precursors selectively 
(16-18)  this was  interpreted to indicate that  the ability of anti-CRI  antibodies  to 
inhibit DTH is dependent upon the ability of the antiserum to activate Ts. Anti-CRI 
antibodies were thus unable to inhibit immune T  cells directly. This postulate was 
further supported  by the  finding  that  anti-CRI  antibodies  given before challenge 
failed to inhibit DTH (data not shown). 
Studies from many different experimental systems have already provided evidence 
indicating that the expression of particular idiotypes on T  and B cells is linked to the 
presence of distinct heavy-chain allotypes genes (20-22, 24).  Because this linkage is 
observed both at the T- and B-cell levels, it has been suggested that both B and T 
cells  employ  the  same  VH  genes  to  encode constituents  of their  receptors.  These 
findings are in accord with our observation that anti-CRI antibodies of the A/J strain 
were  able  to  inhibit  the  development  of DTH  in  C.AL-20  mice,  which  have  an 
allotype similar to that of A/J and which produce humoral antibodies with the CRI 
BALB/c mice.  Thus,  inheritance of the  ability of anti-CRI  antibodies  to  activate 
suppressor T  cells is also linked to the heavy-chain Igh-1 allotype locus. Recent reports 
from this laboratory (12) have shown that suppressor factors induced by intravenous 
injection of  ABA-coupled cells in A/J mice also bear CRI determinants, the expression 1226  ANTIGEN-  AND RECEPTOR-DRIVEN REGULATORY MECHANISMS 
of which was also linked to the allotype-linkage group of genes. The Ts from which 
these TsF are derived as well as Ts induced by anti-idiotype have now been shown to 
bear idiotypic determinants on their surface  (M.-S.  Sy, A.  Nisonoff, B.  Benacerraf, 
and M. I. Greene. Manuscript in preparation.). Therefore, suppressor T  cells, induced 
by antigen or by anti-idiotype in the absence of antigen, and suppressor factors bear 
idiotypic determinants similar to the determinants found in antibodies. These studies 
provide evidence that passively administered anti-CRI antibodies mimic the action of 
antigen-coupled cells.  However, whether the suppressor T  cells induced by these two 
apparently  different methods belong to the same T-cell subpopulation  or actually 
represent two different T-cell subpopulations is now under investigation. In conclu- 
sion,  these  studies  reveal  that  antigen-independent  stimulation  of antigen-specific 
regulatory T  cells by antibodies to idiotypic determinants on B-cell products can be 
a  potent tool to analyze immunological responses, presumably in terms of receptor 
anti-receptor interactions. 
Summary 
Delayed-type hypersensitivity (DTH) to the azobenzenearsonate (ABA) hapten can 
be readily induced in A/J mice injecting ABA-coupled syngeneic spleen cells subcu- 
taneously. To further characterize this T-cell-dependent immunological phenomenon, 
the effect of passively administered anti-cross-reactive idiotype common to anti-ABA 
antibodies of A/J mice (CRI)  antibodies on the development of ABA-specific DTH 
was  investigated.  Animals  given daily  injections  (of minute  amounts)  of anti-CRI 
antibodies  subsequent  to  immunization  with  ABA-coupled  cells  show  significant 
reduction of ABA specific responses. This inhibition is antigen specific and requires 
the intact  immunoglobulin molecule, as F(ab')2 treatments were ineffective in sup- 
pressing the reaction. 
Investigations of the mechanism of the anti-CRI-induced suppression of ABA DTH 
revealed that the observed suppression is a result of the activation of suppressor cells. 
Spleen  cells  taken  from  animals  which  received anti-CRI  antibodies  were  able  to 
adoptively transfer suppression to naive recipients. This suppression was shown to be 
mediated  by  T  cells,  as  anti-Thyl.2  plus  complement  completely  abrogated  the 
transfer of suppression. In addition, animals pretreated with low doses of cyclophos- 
phamide were not suppressed by the administration of anti-CRI antibodies. 
The genetic restriction of anti-CRI-induced suppression was demonstrated. Anti- 
bodies to the major cross-reactive idiotype, (CRI) associated with anti-ABA antibodies 
in A/J mice were unable to suppress the development of DTH to ABA in BALB/c 
mice (H-2  a, Igh-1"). Such antibodies were, however, fully active in suppressing ABA 
DTH in the allotype-congenic C.AL-20 strain which has an allotype (Igh-1 d) similar 
to  that  of A/J  (Igh-1 e)  on  a  BALB/c background,  and  which  produces  humorai 
antibodies with the CRI. 
Received  for publication 24July 1979. 
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